Health

Teixobactin And iChip Promise Hope Against Antibiotic Resistance

web-MRSA-rex

 

(Forbes) – Teixobactin is the first new class of antibiotic announced in decades. That news and even more importantly, the elegant way it was discovered, are the most exciting news I’ve seen in some time.

Antibiotic development has stagnated as pharmaceutical companies have instead turned their attention to the far more profitable ventures of drugs for chronic diseases, like diabetes or heart disease. Antibiotics had been relegated to the role of the unwanted stepchild, it seemed.

Yet as antibiotics have been overused by healthcare workers (often at the demand of patients), sold over-the-counter in many countries, and wasted by agricultural misuse, we have seen their efficacy diminish.

Globally, deaths due to antibiotic resistance are estimated at 700,000/year. In the US alone, infections number 2 million/year, with 23,000⁠ deaths due to resistant organisms. With the explosion of antibiotic resistance and the recent projections that, by 2050, antibiotic resistance would cost the world up to 100 trillion USD and a reduction of 2% to 3.5% in Gross Domestic Product (GDP), there has finally been renewed interest in antibiotic development.

READ MORE

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker